Patents

US 9801860 B2: Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent

Granted
2017-10-31
Filed
2015-11-18 application 14945397
Type
Utility · 20 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Disclosed herein are pharmaceutical compositions, methods and kits for lowering the serum uric acid level of a subject and for the treatment of a condition associated with elevated serum uric acid levels comprising administering a composition comprising a first urate-lowering agent and a second urate-lowering agent. In some aspects the first urate-lowering agent is (−)-halofenate, (−)-halofenic acid, or a pharmaceutically acceptable salts thereof. In some aspects the second urate-lowering agent is an inhibitor of uric acid production, a uricosuric agent, a uricase, or a pharmaceutically acceptable salt thereof.

Source: PVGPATDIS, file of 2026-04-10 (ipg171031.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
CymaBay Therapeutics, Inc. 43 patentsUS company or organizationNewark, CACymaBay Therapeutics, Inc. Form D issuer EXACT high confidence: identical full name and state
CYMABAY THERAPEUTICS, INC. SEC filer EXACT medium confidence: identical full name, one of each nationally
PVGPATDIS, file of 2026-04-10
Diatex Co., Ltd. 11 patentsForeign company or organizationSan Antonio, TXPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Brian K. RobertsPalo Alto, CA15PVGPATDIS, file of 2026-04-10
Gopal Chandra SahaDublin, CA6PVGPATDIS, file of 2026-04-10
Brian Edward LavanSan Francisco, CA7PVGPATDIS, file of 2026-04-10
Charles A. McWherterOakland, CA34PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/426PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2016-06-29Assignment
Assignment of assignor's interest
CYMABAY THERAPEUTICS, INC. signed 2016-06-29DIATEX, INC. SAN ANTONIO, TX39045/152ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.